Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis
2011

Understanding Patient Loss to Follow-Up in South Africa's Antiretroviral Therapy Program

Sample size: 6411 publication 10 minutes Evidence: high

Author Information

Author(s): Van Cutsem Gilles, Ford Nathan, Hildebrand Katherine, Goemaere Eric, Mathee Shaheed, Abrahams Musaed, Coetzee David, Boulle Andrew

Primary Institution: Médecins Sans Frontières, Cape Town, South Africa

Hypothesis

What is the impact of correcting mortality data on the understanding of loss to follow-up in antiretroviral therapy programs?

Conclusion

High mortality rates among patients lost to follow-up were identified, particularly in the early months after starting treatment, highlighting the need for improved monitoring and support.

Supporting Evidence

  • 28.8% of patients lost to follow-up had died within 3 months after their last clinic visit.
  • Mortality rates were highest among patients who had recently started ART.
  • True loss to follow-up increased with time on ART.
  • Young age and higher CD4 counts were associated with higher true loss to follow-up.
  • 78% of deaths occurred within the first 3 months after the last visit.

Takeaway

Many patients who stop going to their doctor for HIV treatment may actually have died, especially soon after they last visited. We need to check on these patients better.

Methodology

The study analyzed data from 6411 patients on ART, using national death registry linkages to ascertain vital status and correct mortality estimates.

Potential Biases

Potential biases include differences between those traced for vital status and those who were not, as well as underestimating mortality among patients without civil identification numbers.

Limitations

The study focused only on patients who had initiated ART, potentially overlooking those who defaulted before starting treatment.

Participant Demographics

Median age at enrollment was 32 years, with 68% being women.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 6.2–7.6

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0014684

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication